Blog

A primary care provider is discussing Tdap vaccine administration in pregnant populations with their advanced practitioner student. Which of the following statements by the student indicates a need for further teaching?

The primary care provider is preparing to prescribe isosorbide dinitrate sustained release for a patient with chronic, stable angina. What initial dosing should be recommended?

A patient presents to their primary care provider (PCP) complaining of abdominal pain, frequent loose stools, and an intermittent, mild fever. The patient has been taking cefaclor for the past 5 days for the treatment of tonsillitis. The provider should:

A patient has been taking an opioid analgesic for chronic pain and tells the primary care provider that the medication doesn’t work well anymore. The provider should suspect drug:

A patient has been taking an opioid analgesic for 2 weeks after a minor outpatient procedure. At a follow-up clinic visit, the patient tells the primary care provider that he took extra doses for the past 2 days because of increased pain and wants an early refill of the medication. The provider should suspect:

A 70-year-old patient describes moderate pain associated with osteoarthritis (OA) in their fingers, thumbs, hips, and knees. The patient is currently taking high-dose acetaminophen with only mild relief. The patient has a strong family history of cardiovascular disease and has been diagnosed with hypertension. To help alleviate this patient’s pain, the primary care provider should consider prescribing:

A patient with a history of angina has been prescribed sublingual nitroglycerin tablets to use as needed. Which statement by the patient indicates the understanding of medication?

____________ bind to and later alter reverse transcriptase.

A primary care provider is evaluating a patient with stage C heart failure. They are currently taking carvedilol 50 mg twice daily and valsartan 160 mg twice daily. Their most recent echocardiogram has showed only minimal improvement in EF, from 25% to 30%, since reaching the target dosages for both medications. The provider should:

A male patient with benign prostatic hypertrophy (BPH) has been prescribed the nonspecific α1-adrenergic antagonist terazosin for symptom relief. The patient asks the primary care provider how this medication works. What is the best response?